期刊文献+

异基因造血干细胞移植治疗慢性髓系白血病的现状和进展

下载PDF
导出
摘要 异基因造血干细胞移植是治愈慢性髓系白血痫(CML)的唯一手段。酪氨酸激酶抑制剂伊吗替尼的成功临床实践为CML的治疗带来了新的选择,也为造血干细胞移植的改进开启了新的思路。本文就异基因造血干细胞移植治疗CML的现状、进展以及酪氨酸激酶抑制剂伊吗替尼在造血干细胞移植中的应用进行综述。
出处 《国外医学(输血及血液学分册)》 2005年第4期349-351,共3页 Foreign Medical Sciences(Section of Blood Transfusion and Heanatology)
  • 相关文献

参考文献20

  • 1Barrett J. Allogeneic stem cell transplantation for chronic myeloid leukemia. Semin Hematol, 2003, 40(1): 59-71.
  • 2Druker BJ, O'Brien SG, Cortes J, et al. Chronic myelogenous leukemia. Hematology, 2002,111-135.
  • 3Gratwohl A, Hermans J, Goldman JM, et al. Risk assessment for patients with chronic myeloid leukemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet,1998, 352(9134): 1087-1092.
  • 4Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol, 1997, 15(5): 1767-1777.
  • 5Hansen J, Gooley TA, Matin P J, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.N Engl J Med, 1998, 338(14): 962-968.
  • 6Or R, Shapira MY, Resnic I, et al. Nomyeloablative allogeneic stem cell transplantation for treatment of chronic myeloid leukemia in first chronic phase. Blood, 2003, 101 (2): 441-445.
  • 7Sandmaier BM, Hegenbart U, Shizuru J, et al. Nomyeloablative allogeneic stem cell transplantation (SCT) From HLA identical siblings for treatment of chronic myelogenous leukemia (CML) :induction of molecular remissions. Blood, 2001, 98 (11 ) : 371 b.
  • 8Crawley CR, Lalancette M, Szydlo R, et al. Reduced intensity conditioned allografts for chronic myeloid leukemia: a study from chronic leukaemia working party of the EBMT. Blood, 2002(16):781a.
  • 9Marks DI, Lush R, Cavenagh J, et al. The toxicity and efficacy of donor lymphocyte infusion given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood, 2002,100(9): 3108-3144.
  • 10Elmaagacli AH, Peceny R, Steckel N, et al. Outcome of transplantation of highly purified peripheral blood CD34 + cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia.Blood, 2003, 101 (2): 446-453.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部